Ross CJD - Search Results

1

Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components.

Kazemian P, Yu SY, Thomson SB, Birkenshaw A, Leavitt BR, Ross CJD. Kazemian P, et al. Among authors: ross cjd. Mol Pharm. 2022 Jun 6;19(6):1669-1686. doi: 10.1021/acs.molpharmaceut.1c00916. Epub 2022 May 20. Mol Pharm. 2022. PMID: 35594500 Free PMC article. Review.

2

CRISPR/Cas9 Editing: Sparking Discussion on Safety in Light of the Need for New Therapeutics.

Carlaw TM, Zhang LH, Ross CJD. Carlaw TM, et al. Among authors: ross cjd. Hum Gene Ther. 2020 Aug;31(15-16):794-807. doi: 10.1089/hum.2020.111. Epub 2020 Jul 24. Hum Gene Ther. 2020. PMID: 32586150 Review.

3

A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency.

Al-Shekaili HH, Petkau TL, Pena I, Lengyell TC, Verhoeven-Duif NM, Ciapaite J, Bosma M, van Faassen M, Kema IP, Horvath G, Ross C, Simpson EM, Friedman JM, van Karnebeek C, Leavitt BR. Al-Shekaili HH, et al. Hum Mol Genet. 2020 Nov 25;29(19):3266-3284. doi: 10.1093/hmg/ddaa202. Hum Mol Genet. 2020. PMID: 32969477 Free PMC article.

4

Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG.

Yu SY, Birkenshaw A, Thomson T, Carlaw T, Zhang LH, Ross CJD. Yu SY, et al. Among authors: ross cjd. CRISPR J. 2022 Apr;5(2):187-202. doi: 10.1089/crispr.2021.0109. Epub 2022 Mar 2. CRISPR J. 2022. PMID: 35238621 Review.

5

Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.

Ross CJ, Twisk J, Meulenberg JM, Liu G, van den Oever K, Moraal E, Hermens WT, Rip J, Kastelein JJ, Kuivenhoven JA, Hayden MR. Ross CJ, et al. Hum Gene Ther. 2004 Sep;15(9):906-19. doi: 10.1089/hum.2004.15.906. Hum Gene Ther. 2004. PMID: 15353045

6

Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease.

Wright GEB, Caron NS, Ng B, Casal L, Casazza W, Xu X, Ooi J, Pouladi MA, Mostafavi S, Ross CJD, Hayden MR. Wright GEB, et al. Among authors: ross cjd. Hum Mol Genet. 2020 Sep 29;29(16):2788-2802. doi: 10.1093/hmg/ddaa184. Hum Mol Genet. 2020. PMID: 32898862 Free PMC article.

7

Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.

Ross CJ, Twisk J, Bakker AC, Miao F, Verbart D, Rip J, Godbey T, Dijkhuizen P, Hermens WT, Kastelein JJ, Kuivenhoven JA, Meulenberg JM, Hayden MR. Ross CJ, et al. Hum Gene Ther. 2006 May;17(5):487-99. doi: 10.1089/hum.2006.17.487. Hum Gene Ther. 2006. PMID: 16716106

8

The emerging era of pharmacogenomics: current successes, future potential, and challenges.

Lee JW, Aminkeng F, Bhavsar AP, Shaw K, Carleton BC, Hayden MR, Ross CJ. Lee JW, et al. Clin Genet. 2014 Jul;86(1):21-8. doi: 10.1111/cge.12392. Epub 2014 May 9. Clin Genet. 2014. PMID: 24684508 Free PMC article. Review.

9

A Systematic Review of Polygenic Models for Predicting Drug Outcomes.

Siemens A, Anderson SJ, Rassekh SR, Ross CJD, Carleton BC. Siemens A, et al. Among authors: ross cjd. J Pers Med. 2022 Aug 27;12(9):1394. doi: 10.3390/jpm12091394. J Pers Med. 2022. PMID: 36143179 Free PMC article. Review.

10

Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation.

Ross CJ, Liu G, Kuivenhoven JA, Twisk J, Rip J, van Dop W, Excoffon KJ, Lewis SM, Kastelein JJ, Hayden MR. Ross CJ, et al. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2143-50. doi: 10.1161/01.ATV.0000176971.27302.b0. Epub 2005 Jul 7. Arterioscler Thromb Vasc Biol. 2005. PMID: 16002740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page